New Quality Assessment Office Will Enhance CMC Review Efficiency – Winkle
This article was originally published in The Tan Sheet
Executive Summary
The establishment of CDER's new Office of New Drug Quality Assessment (ONDQA) will help to make the CMC review process more efficient and will address workload problems, according to Office of Pharmaceutical Science Director Helen Winkle, MD.